latest news releases from the newsroom
GoldSpring, Inc. Receives Contract for a State-of-the-Art, Turnkey Gravity Gold Production Plant, Capable of Processing up to 200 tons/hr, for Initial Gold Production on the Company's Placer Gold Claims in Nevada
SCOTTSDALE, Ariz., June 2, 2003 (PRIMEZONE) -- GoldSpring, Inc. (OTCBB:GSPG) announces today that the Company has signed a Manufacturing Contract for a turnkey Gravity Gold Recovery Plant, with capacity of up to 200 tons per hour, with RMS-Ross Corporation, of Chilliwack, British Columbia, Canada. The Company has negotiated terms on the total cost of the turnkey package of $515,455.00, which will enable construction to begin and delivery within 12-14 weeks. The plant includes a Gold Room for $101,000.00 which will provide the required security for the recovery operation as well as assuring higher recovery through a state-of-the-art finishing circuit.
Stolt-Nielsen S.A. Anticipates Reporting a Loss in 2003
LONDON, June 2, 2003 (PRIMEZONE) -- Stolt-Nielsen S.A. (Nasdaq:SNSA) (Oslo:SNI) announced that in light of today's announcement of a significant loss by its publicly traded subsidiary, Stolt Offshore S.A. (Nasdaq:SOSA) (Oslo Stock Exchange:STO), SNSA now anticipates to report a loss in 2003.
Coram Healthcare To Provide New Alpha-1 Therapy, Aralast
DENVER, June 2, 2003 (PRIMEZONE) -- Coram Healthcare Corporation (OTCBB:CRHEQ), a leading national provider of specialized home infusion services, today announced that it has been selected by Baxter Healthcare Corporation as a national provider of Aralast(tm), a new drug for use in the treatment of Alpha-1-Antitrypsin Deficiency (Alpha-1). Alpha-1 is a hereditary disorder characterized by a reduction of serum levels of Alpha-1, emphysema, and occasionally liver disease.